Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: Meta-analysis of three genome-wide association studies

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Nolte, Ilja M ^a   Wallace, Chris ^b   Newhouse, Stephen J ^b   Waggott, Daryl ^c   Fu, Jingyuan ^a,d   Soranzo, Nicole ^e,f   Gwilliam, Rhian ^e   Deloukas, Panos ^e   Savelieva, Irina ^g   Zheng, Dongling ^g   Dalageorgou, Chrysoula ^g   Farrall, Martin ^h   Samani, Nilesh J ⁱ   Connell, John ^j   Brown, Morris ^k   Dominiczak, Anna ^j   Lathrop, Mark ^l   Zeginni, Eleftheria ^e,h   Wain, Louise V ^m   Newton Cheh, Christopher ^n,o,p   Eijgelsheim, Mark ^q   Rice, Kenneth ^r   De Bakker, Paul I W ^o,s   Pfeufer, Arne ^t,u   Sanna, Serena ^v   Arking, Dan E ^w   Asselbergs, Folkert W ^a,d   Spector, Tim D ^f   Carter, Nicholas D ^g   Jeffery, Steve ^g   Tobin, Martin ^m   Caulfield, Mark ^b   Snieder, Harold ^a,f   Paterson, Andrew D ^x   Munroe, Patricia B ^b   Jamshidi, Yalda ^g   more..

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j UNIVERSITY OF GLASGOW   (United Kingdom)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^m UNIVERSITY OF LEICESTER   (United Kingdom)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^o BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^p FRAMINGHAM HEART STUDY   (United States)

^q ERASMUS MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF WASHINGTON   (United States)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^u INSTITUTE OF EPIDEMIOLOGY   (Germany)

^v CNR   (Italy)

^w JOHNS HOPKINS UNIVERSITY   (United States)

^x HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE ADAPTOR PROTEIN; PHOSPHOLAMBAN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHROMOSOME 6; COHORT ANALYSIS; COMPUTER MODEL; DIASTOLE; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; MALE; QT INTERVAL; SHORT QT SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; HEART; META ANALYSIS; PHYSIOLOGY;

CALCIUM-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 6; COHORT STUDIES; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HEART; HUMANS;

EID: 67650280679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006138     Document Type: Article

References (67)

1. Patel ND, Singh BK, Mathew ST (2006) The heterogeneous spectrum of the long QT syndrome. Eur J Intern Med 17: 235-240.
2. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, et al. (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84: 1516-1523.
3. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR (2004) Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol 43: 565-571.
4. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, et al. (1992) Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8: 690-695.
5. Luo S, Michler K, Johnston P, Macfarlane PW (2004) A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 37 Suppl: 81-90.
6. Reardon M, Malik M (1996) QT interval change with age in an overtly healthy older population. Clin Cardiol 19: 949-952.
7. Yang H, Elko P, LeCarpentier GL, Baga J, Fromm B, et al. (1994) Sex differences in the rate of cardiac repolarization. J Electrocardiol 27 Suppl: 72-73.
8. Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350: 1013-1022.
9. Busjahn A, Knoblauch H, Faulhaber HD, Boeckel T, Rosenthal M, et al. (1999) QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 99: 3161-3164.
10. Carter N, Snieder H, Jeffery S, Saumarez R, Varma C, et al. (2000) QT interval in twins. J Hum Hypertens 14: 389-390.
11. Dalageorgou C, Ge D, Jamshidi Y, Nolte IM, Riese H, et al. (2008) Heritability of QT interval: how much is explained by genes for resting heart rate? J Cardiovasc Electrophysiol 19: 386-391.
12. Pietila E, Fodstad H, Niskasaari E, Laitinen PP, Swan H, et al. (2002) Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol 40: 511-514.
13. Newton-Cheh C, Guo CY, Larson MG, Musone SL, Surti A, et al. (2007) Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 116: 1128-1136.
14. Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, et al. (2005) Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res 96: 693-701.
15. Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, et al. (2003) A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 59: 27-36.
16. Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, et al. (2007) Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 15: 974-979.
17. Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, et al. (2005) Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet 13: 1213-1222.
18. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, et al. (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38: 644-651.
19. Post W, Shen H, Damcott C, Arking DE, Kao WH, et al. (2007) Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish. Hum Hered 64: 214-219.
20. Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, et al. (2007) Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 116: 10-16.
21. Tobin MD, Kahonen M, Braund P, Nieminen T, Hajat C, et al. (2008) Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int J Epidemiol 37: 1132-1141.
22. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, et al. (2008) Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 57: 1108-1114.
23. Eijgelsheim M, Aarnoudse AL, Rivadeneira F, Kors JA, Witteman JC, et al. (2009) Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration. Hum Mol Genet 18: 347-357.
24. Raitakari OT, Blom-Nyholm J, Koskinen TA, Kahonen M, Viikari JS, et al. (2009) Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study. Ann Med 41: 144-151.
25. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, et al. (2009) Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 41: 399-406.
26. Pfeufer A, Sanna S, Arking DE, Muller M, Gateva V, et al. (2009) Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 41: 407-414.
27. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55: 997-1004.
28. Ge D, Zhang K, Need AC, Martin O, Fellay J, et al. (2008) WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 18: 640-643.
29. Pe'er I, Yelensky R, Altshuler D, Daly MJ (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32: 381-385.
30. Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32: 227-234.
31. Marjamaa A, Newton-Cheh C, Porthan K, Reunanen A, Lahermo P, et al. (2008) Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med.
32. Goring HH, Terwilliger JD, Blangero J (2001) Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 69: 1357-1369.
33. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
34. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, et al. (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75: 401-409.
35. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, et al. (1996) Phospholamban gene dosage effects in the mammalian heart. Circ Res 78: 839-847.
36. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, et al. (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299: 1410-1413.
37. Minamisawa S, Sato Y, Tatsuguchi Y, Fujino T, Imamura S, et al. (2003) Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 304: 1-4.
38. Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG (2001) Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol 33: 1345-1353.
39. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, et al. (1995) Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784.
40. Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, et al. (2006) A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A 103: 1388-1393.
41. Wu Y, MacMillan LB, McNeill RB, Colbran RJ, Anderson ME (1999) CaM kinase augments cardiac L-type Ca2+ current: a cellular mechanism for long QT arrhythmias. Am J Physiol 276: H2168-H2178.
42. del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, et al. (2004) Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A 101: 5622-5627.
43. Xu Y, Zhang Z, Timofeyev V, Sharma D, Xu D, et al. (2005) The effects of intracellular Ca2+ on cardiac K+ channel expression and activity: novel insights from genetically altered mice. J Physiol 562: 745-758.
44. Li J, Marionneau C, Zhang R, Shah V, Hell JW, et al. (2006) Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents. Circ Res 99: 1092-1099.
45. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 19;96: 657-662.
46. Loyer X, Gomez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, et al. (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117: 3187-3198.
47. Zhang YH, Zhang MH, Sears CE, Emanuel K, Redwood C, et al. (2008) Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 102: 242-249.
48. DeWitt MM, MacLeod HM, Soliven B, McNally EM (2006) Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol 48: 1396-1398.
49. van Spaendonck-Zwarts KY, van den Berg MP, van Tintelen JP (2008) DNA analysis in inherited cardiomyopathies: current status and clinical relevance. Pacing Clin Electrophysiol 31 Suppl 1: S46-S49.
50. Marjamaa A, Newton-Cheh C, Porthan K, Reunanen A, Lahermo P, et al. (2008) Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med.
51. Becker ML, Visser LE, Newton-Cheh C, Hofman A, Uitterlinden AG, et al. (2009) A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers. Br J Clin Pharmacol 67: 61-67.
52. Becker ML, Aarnoudse AJ, Newton-Cheh C, Hofman A, Witteman JC, et al. (2008) Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea. Pharmacogenet Genomics 18: 591-597.
53. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512.
54. Teo YY, Inouye M, Small KS, Gwilliam R, Deloukas P, et al. (2007) A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics 23: 2741-2746.
55. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
56. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
57. Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, et al. (2001) Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res 4: 464-477.
58. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
59. Patterson N, Price AL, Reich D (2006) Population structure and eigenanalysis. PLoS Genet 2: e190.
60. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 35: 530-545.
61. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22: 99-111.
62. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
63. Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS (2007) The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 30: 2107-2112.
64. Marchini J, Howie B, Myers S, McVean G, Donnelly P (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
65. Li Y, Abecasis GR (2006) Mach 1.0: Rapid Haplotype Reconstruction and Missing Genotype Inference. Am J Hum Genet S. pp 2290.
66. Huber PJ (1967) The behavior of maximum likelihood estimates under nonstandard conditions. Proc Fifth Berkeley Symposium Math Stat 1: 221-223.
67. White H (1982) Maximum Likelihood Estimation of Misspecified Models. Econometrica 50: 1-26.